Business
The Series B extension brings the round to $35 million, raising Hyro's total funding to $50 million.
The company will use the funds to enhance its R&D strategy, advance its SEEDIT platform and boost product development.
The company will use the funds to accelerate the commercialization of its TAPS therapy and enhance the visibility of its offerings among providers and patients.
Former HealthTap employees allege that Mohr Davidow Ventures and company leaders stripped them of equity to position the company for a profitable turnaround benefiting MDV.
The company will use the funds to expand its commercial growth and clinical-evidence generation.
The company aims to empower physicians with job transparency, financial tools and a peer community to enhance workplace fulfillment and autonomy.
The gunman reportedly targeted Thompson, waiting for him as he arrived at an investors' conference in Midtown Manhattan.
The company will use the funds to support its ongoing clinical trial, ramp up production and sales for its OtoSight Middle Ear Scope and relocate its headquarters.
The company will use the funds to try and level the playing field between payers and providers.
The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.